Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions

被引:112
作者
Kumazaki, K
Nakayama, M
Suehara, N
Wada, Y
机构
[1] Osaka Med Ctr, Dept Mol Med, Izumi Ku, Osaka 5941101, Japan
[2] Osaka Med Ctr, Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan
[3] Osaka Med Ctr, Dept Pathol & Lab Med, Osaka 5941101, Japan
[4] Osaka Med Ctr, Dept Obstet, Osaka 5941101, Japan
关键词
vascular endothelial growth factor; placental growth factor; fms-like tyrosine kinase; kinase insert domain-containing region; pathologic placenta;
D O I
10.1053/hupa.2002.129420
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The vascular endothelial growth factor (VEGF) family and its receptors have multifunctional activities besides angiogenesis, and some of these molecules are induced by hypoxia/ischemia. They are known to be expressed in human placenta, but little is known about their involvement in pathologic conditions. We have investigated the expression patterns of VEGF, placental growth factor (PIGF), and their receptors fms-like tyrosine kinase (Flt-1) and kinase insert domain-containing region (KDR) in placentas with histopathological changes. Forty-two placentas from normal and complicated pregnancies delivered in the second and third trimesters were fixed with paraformaldehyde and embedded in paraffin. In situ hybridization and immunohistochemistry were performed on serial sections. In the villi with characteristic hypoxic/ischemic changes (HIC), including increased syncytial knots, infarction, or hypercapillarization, intense immunostaining for VEGF was detected in the media of blood vessels, and increased staining for KDR was demonstrated in the endothelial cells. Strong PIGF inummoreactivity was localized to the degenerative trophoblasts around the infarctions. Marked Flt-1 mRNA expression in the syncytiotrophoblast layers of HIC villi was identified, but some samples did not show ligand expression in these regions. Positive immunostaining for VEGF, PIGF, and Flt-1 was observed in infiltrated neutrophils and macrophages in the placentas with chorioamnionitis (CAM). These findings suggested that in the hypoxic/ischemic regions, VEGF and KDR expression is increased within the villous vessels by paracrine regulation, whereas the expression of PIGF and Flt-1 is enhanced in villous trophoblasts by autocrine regulation. The FIt-I gene may also be up-regulated directly by hypoxia/ischemia independently of ligand mediation. Furthermore, the results indicated that VEGF and PIGF stimulate inflammatory cell migration by autocrine regulation via the FIt-I receptor in the CAM placenta. Thus, various functions of VEGF family members participate in the development of pathologic changes in the placenta. HUM PATHOL 33: 1069-1077. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1069 / 1077
页数:9
相关论文
共 24 条
[1]   COLOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS FLT-1 RECEPTOR IN HUMAN PLACENTA [J].
AHMED, A ;
LI, XF ;
DUNK, C ;
WHITTLE, MJ ;
RUSHTON, DI ;
ROLLASON, T .
GROWTH FACTORS, 1995, 12 (03) :235-243
[2]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[3]   Role of the placenta in perinatal pathology (revisited) [J].
Altshuler, G .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (02) :207-233
[4]  
Altshuler G, 1995, Semin Pediatr Neurol, V2, P90, DOI 10.1016/S1071-9091(05)80007-5
[5]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[6]  
Benirschke K, 2000, PATHOLOGY HUMAN PLAC
[7]   EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS FLT AND KDR IN OVARIAN-CARCINOMA [J].
BOOCOCK, CA ;
CHARNOCKJONES, DS ;
SHARKEY, AM ;
MCLAREN, J ;
BARKER, PJ ;
WRIGHT, KA ;
TWENTYMAN, PR ;
SMITH, SK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07) :506-516
[8]   Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression [J].
Brogi, E ;
Schatteman, G ;
Wu, T ;
Kim, EA ;
Varticovski, L ;
Keyt, B ;
Isner, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :469-476
[9]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[10]   Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation [J].
Clark, DE ;
Smith, SK ;
Licence, D ;
Evans, AL ;
Charnock-Jones, DS .
JOURNAL OF ENDOCRINOLOGY, 1998, 159 (03) :459-467